Joslin Diabetes Center researchers find bariatric surgery to be more effective at weight control than medical and lifestyle interventions for type 2 diabetes.

BOSTON – Joslin Diabetes Center announced today that Stefany A. Shaheen has joined the board of trustees as a new member. Joslin's board is made up of dedicated professionals with a wealth of personal ...

BOSTON, MA — A new study from Joslin Diabetes Center explores the role of insulin signaling in the brain’s immune cells, and how it may mediate the relationship between type 2 diabetes and Alzheimer’s ...

The premiere research institution dedicated entirely to diabetes, Joslin is driving the innovation and discovery that will bring us closer to a cure. Each year, Joslin’s 250-plus researchers across 27 ...

Boston, MA – Investigators at Joslin Diabetes Center have conducted the first comprehensive clinical characterization of cognitive decline in people with long-duration type 1 diabetes (T1D). Published ...

Medha N. Munshi, MD, a geriatrician and endocrinologist at Beth Israel Deaconess Medical Center, has dedicated her career to improving care for older adults. In 2001, she founded the Geriatric ...

Beginning June 1, 2024, Beth Israel Lahey Health (BILH) introduced a new patient portal called MyBILH Chart along with a new electronic health record called Epic. Over the next two years, this ...

BOSTON – Rohit N. Kulkarni, MD, PhD, the Diabetes and Wellness Research Foundation Endowed Chair and Co-Head of the Section on Islet & Regenerative Biology at Joslin Diabetes Center, has been awarded ...

Congratulations to Joslin Diabetes Center Principal Investigators Drs. Susan Bonner-Weir, Laurie Goodyear, Jean Schaffer and Yu-Hua Tseng for being named to the 2024 WIELD Trailblazers: Women Sharping ...

BOSTON – A serious complication of both type 1 and type 2 diabetes, diabetic retinopathy is a progressive eye disease characterized by damage to blood vessels in the retina, the light sensitive tissue ...

BOSTON – About eight million people live with Type 1 diabetes (T1D) worldwide, a chronic autoimmune condition in which the body attacks and destroys its own insulin-producing β-cells (pronounced “beta ...